Evaluation of ST13 and BCL11B Gene Expression Levels in Early Diagnosis of Parkinson's Disease

LU Xue-sheng,XU Min,ZHANG Yan,YAO Sheng-qi,ZHANG Yun,DONG Qiang
DOI: https://doi.org/10.3870/sjsscj.2010.05.001
2010-01-01
Abstract:Objective:Objective: To explore the possibility of ST13 and BCL11B expression levels as biomarkers in the early molecular diagnosis of Parkinson's Disease(PD).Methods: By real-time PCR,the expression levels of peripheral blood ST13 and BCL11B have been compared in PD patients at different stages.Measurements were also compared with health controls.Results: The expression of peripheral blood ST13 and BCL11B were both expressed at low levels in PD patients.In contrast,the changes in ST13 expression levels were not obvious until PD patients reached Hoehn-Yahr stage II or above.Conclusion: The expression of ST13 and BCL11B in peripheral blood may both serve as potential biomarkers for PD diagnosis,but the expression of BCL11B seems to be a better one since it displays a remarkable change at early stages of PD.
What problem does this paper attempt to address?